Sunmax Pharma Limited - Due diligence report

A 360° intelligence report on Sunmax Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress …

2003-09-26 Chandigarh, Chandigarh Active Unlisted Active Compliant
Share
Connect MCP
SP Sunmax Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Sunmax Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
71/100
Trust Score
Moderate

Sunmax Pharma Limited is assessed as Moderate with a Trust Score of 71/100. Sunmax Pharma Limited is an active public limited indian non-government company incorporated in 2003, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 08 Aug 2026 from the latest processed filings. Sunmax Pharma Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
71/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
35/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.

Charges position: 1 open (10.75 cr) · 1 satisfied (6.62 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Union Bank Of India1 48.0 cr
Compliance Score: 86/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
AAROHI AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
ANKIT AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
ROHAN AGARWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 60
Growth signals & trust indicators
Operating for 22+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 10.75 cr already registered.
  • Compliance record supports lending.
Investor view46/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
15 Nov 2023
Director ceased
AAROHI AGARWAL
31 Mar 2020
Share transfer (FY 2020)
1000.00000000 shares to JK AGARWAL
12 Nov 2018
Director appointed
AAROHI AGARWAL (Director)
Director ceased
POONAM AGARWAL
25 Apr 2018
Charge satisfied
Union Bank Of India
23 Mar 2018
Charge created
Others - 10.75 cr
31 Mar 2012
Securities allotted
200000.00 Equity Shares - 20.00 Lakh raised
02 Apr 2011
Director appointed
ROHAN AGARWAL (Director)
Director ceased
DARSHAN DAYAL AGARWAL
04 Aug 2007
Charge created
Union Bank Of India - 6.62 cr
01 Jan 2005
Director appointed
ANKIT AGARWAL (Director)
26 Sep 2003
Incorporated
Registered with Roc Chandigarh
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2023 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Galaxy Emulsifiers Private Limited U40856MH1986PTC040856 Navi Mumbai, Maharashtra, India
Al Arsh Conchem Private Limited U24110GJ2018PTC104903 Vadodara, Gujarat, India
Mahagro Hortitech Industries Private Limited U15117TG2017PTC117643 Hyderabad, Telangana, India
Rise Chemicals Private Limited U24110TG2015PTC098544 Hyderabad, Telangana, India
Uc Colours And Intermediates Private Limited U24100GJ2019PTC110467 Ahmedabad, Gujarat, India
Tenshi U74999KA2016PTC197435 Bangalore South, Karnataka, India
Mc Coy Drugs Private Limited U24230GJ2004PTC098840 Surat, Gujarat, India
Li Shanto Pharmaceuticals Private Limited U24304PN2020PTC193291 Pune, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Sunmax Pharma Limited before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Sunmax Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Sunmax Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Sunmax Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Sunmax Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Sunmax Pharma Limited an active company?

Sunmax Pharma Limited has MCA status “Active” with a compliance score of 86/100 (Low Risk).

Is Sunmax Pharma Limited financially healthy?

Sunmax Pharma Limited has a Financial Health Score of 35/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Sunmax Pharma Limited?

Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Sunmax Pharma Limited?

Promoters hold a majority stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Sunmax Pharma Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Sunmax Pharma Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).

Is it risky to lend to Sunmax Pharma Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.